Dynasil Corp. of America (DYSL)
1.26
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 18.90M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -28.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 58.46% |
Profile
| Dynasil Corp. of America develops, manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through the following three segments: Optics, Innovation & Development and Biomedical. The Optics segment encompasses four business units – Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation, a medical technology incubator which owns rights to certain early-stage medical technologies. The Innovation & Development segment consists of the Radiation Monitoring Devices, Inc. business unit, which is among the largest small business participants in the U.S. government-funded research. The company was founded on October 20, 1960 and is headquartered in Concord, MA. |
| URL | http://www.dynasil.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 13, 2020 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 29, 2024 |
Ratings
Profile
| Dynasil Corp. of America develops, manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through the following three segments: Optics, Innovation & Development and Biomedical. The Optics segment encompasses four business units – Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation, a medical technology incubator which owns rights to certain early-stage medical technologies. The Innovation & Development segment consists of the Radiation Monitoring Devices, Inc. business unit, which is among the largest small business participants in the U.S. government-funded research. The company was founded on October 20, 1960 and is headquartered in Concord, MA. |
| URL | http://www.dynasil.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 13, 2020 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 29, 2024 |